Page last updated: 2024-09-04

rhodioloside and Alveolitis, Fibrosing

rhodioloside has been researched along with Alveolitis, Fibrosing in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, X; Gao, L; He, H; Lin, H; Liu, J; Mao, J; Tang, H; Wu, T1
Bai, Y; Deng, F; Feng, J; Liang, L; Liu, X1

Other Studies

2 other study(ies) available for rhodioloside and Alveolitis, Fibrosing

ArticleYear
Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.
    Cell stress & chaperones, 2016, Volume: 21, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bleomycin; Cell Line; Glucosides; Humans; Lung; NF-E2-Related Factor 2; NF-kappa B; Phenols; Pulmonary Fibrosis; Rats, Sprague-Dawley; Rhodiola; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1

2016
[Salidroside improves pulmonary fibrosis by down-regulation of cathepsin B and NF-κBp65 in rats].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2017, Feb-28, Volume: 42, Issue:2

    Topics: Animals; Cathepsin B; Down-Regulation; Glucosides; Lung; NF-kappa B; Oximetry; Oxygen; Phenols; Pulmonary Fibrosis; Pulmonary Gas Exchange; Pyridones; Rats; Rats, Sprague-Dawley

2017